Pomerantz LLP Issues Reminder to Investors in Quantum Biopharma Ltd. of Class Action – QNTM
NEW YORK CITY, NY / ACCESS Newswire / January 30, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who […]